IOVANCE BIOTHERAPEUTICS, INC.

SAN CARLOS, CA How do I update this listing?

Also known as:

  • LION BIOTECHNOLOGIES INC
  • GENESIS BIOPHARMA INC
  • FREIGHT MANAGEMENT CORP
  • BLACKROCK INC
  • NEW BLACKROCK INC
  • LONGWOOD CAPITAL PARTNERS LLC

Iovance Biotherapeutics is based out of San Carlos. Iovance Biotherapeutics, Inc. operates as a biotechnology company. The Company focuses on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes for treatment of patients with cancer. Iovance Biotherapeutics serves customers in the United States. Whalewisdom has at least 80 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2016-06-15. The notice included securities offered of Equity

Create Email Alert

Contact Info

iovance biotherapeutics, inc.
999 SKYWAY ROAD
SAN CARLOS CA    94070

Business Phone: 6502607120
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Active Schedule 13D and 13G events

Sign in to see

Form 4 - Recent Insider Transactions

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2016-06-15 D BIOTECHNOLOGY Equity 100,000,000 100,000,000 0
2013-11-15 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security 23,290,600 23,290,600 0
2013-06-06 D BIOTECHNOLOGY Equity 1,350,000 1,350,000 0
2011-08-09 D BIOTECHNOLOGY Debt,Option, Warrant or Other Right to Acquire Another Security 5,000,000 5,000,000 0
2011-05-03 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security 1,000,000 500,000 500,000
2011-01-21 D BIOTECHNOLOGY Equity 640,000 640,000 0
2010-11-08 D BIOTECHNOLOGY Equity 250,000 250,000 0
2010-10-01 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 500,000 500,000 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ANTHONY CATALDO subscription required
    DIRECTOR EXECUTIVE OFFICER
DAVID VOYTICKY subscription required
    DIRECTOR
DR. L. STEPHEN COLES subscription required
    DIRECTOR
DR. WILLIAM ANDREWS subscription required
    DIRECTOR
GERALD LEWIS subscription required
    PROMOTER
IBRAHIM ABOTALEB subscription required
    PROMOTER
JAY VENKATESAN subscription required
    DIRECTOR
MANISH SINGH subscription required
    EXECUTIVE OFFICER DIRECTOR
MARIA FARDIS subscription required
    EXECUTIVE OFFICER DIRECTOR
MARK J. AHN subscription required
    DIRECTOR
MARTIN SCHROEDER subscription required
    DIRECTOR
MERRILL A. MCPEAK subscription required
    DIRECTOR
MICHAEL HANDELMAN subscription required
    DIRECTOR EXECUTIVE OFFICER
MICHAEL T. LOTZE subscription required
    EXECUTIVE OFFICER
MOLLY C. HENDERSON subscription required
    EXECUTIVE OFFICER
PAUL KESSLER subscription required
    DIRECTOR
RICHARD MCKILLIGAN subscription required
    EXECUTIVE OFFICER DIRECTOR
ROBERT T. BROOKE subscription required
    EXECUTIVE OFFICER DIRECTOR
RYAN MAYNARD subscription required
    DIRECTOR
SANFORD HILLSBERG subscription required
    DIRECTOR
STEVEN A. FISCHKOFF subscription required
    EXECUTIVE OFFICER
WAYNE ROTHBAUM subscription required
    DIRECTOR

Elevate your investments